Shang Hai Zheng Quan Bao·2025-11-06 19:03Core Viewpoint - Shanghai Pharmaceuticals has decided to abolish its supervisory board and amend its articles of association to enhance corporate governance, transferring the supervisory functions to the audit committee of the board of directors [1]. Group 1: Corporate Governance Changes - The decision to cancel the supervisory board was made during the 26th meeting of the 8th board of directors on November 6, 2025 [1]. - The amendments to the articles of association include the removal of references to the supervisory board and supervisors, and the renaming of the "president's office meeting" to "administrative office meeting" [2]. - The company aims to align its governance structure with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1].